News & HighlightsNews
A unique window into "original antigenic sin"
The body's first blush with a pathogen shapes how it will respond to vaccines. New evidence clarifies how this phenomenon works, mechanistically.
How the body's B cell academy ensures a diverse immune response
A diverse immune response hinges on naive B cells mingling with high affinity ones in the late-stage germinal center. Whether that helps or hinders, however, depends on the virus.
Remembering a pioneer of chromatin biology
Charles David Allis, a molecular biologist who shaped the field of chromatin biology, died on January 8 at the age of 71.
Why older fathers pass on more genetic mutations to their offspring
It's not just the number of mutations that matters. It's the failure to fix them too.
Solving a crucial bottleneck in drug discovery
A novel method reduces the time required to identify novel antibiotic-producing DNA from weeks to days.
When the body's B cell training grounds stay open after hours
While most germinal centers shut down after a few weeks, some stay in business for more than six months. A new study helps explain why.
Intriguing science discoveries of 2022
Breakthroughs in genetics, biochemistry, neuroscience, infectious disease, and drug development were a few of the year's highlights.
Markus Library prepares researchers for new NIH data management policy
The library is offering new tools and training to support researchers operating under an updated NIH policy.
How a cell's mitochondria make their own protein factories
The findings shed a rare light on mitoribosomes, the unique ribosomes found within the cell's mitochondria.
How antibody therapy impacts COVID vaccines
People who receive monoclonal antibodies before vaccines may benefit from increased coverage, due to antibody feedback inhibition.
View
View